Two Sigma Investments LP Sells 16,820 Shares of Red Violet, Inc. (NASDAQ:RDVT)

Two Sigma Investments LP lessened its holdings in Red Violet, Inc. (NASDAQ:RDVT - Free Report) by 69.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,455 shares of the company's stock after selling 16,820 shares during the quarter. Two Sigma Investments LP owned approximately 0.05% of Red Violet worth $270,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of RDVT. Wasatch Advisors LP grew its holdings in shares of Red Violet by 23.7% in the 4th quarter. Wasatch Advisors LP now owns 676,399 shares of the company's stock valued at $24,486,000 after buying an additional 129,519 shares during the period. Arrowstreet Capital Limited Partnership increased its position in shares of Red Violet by 98.7% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 131,988 shares of the company's stock worth $4,778,000 after acquiring an additional 65,561 shares in the last quarter. Russell Investments Group Ltd. lifted its position in Red Violet by 39.7% in the 4th quarter. Russell Investments Group Ltd. now owns 100,244 shares of the company's stock valued at $3,629,000 after acquiring an additional 28,500 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Red Violet by 89.7% during the 4th quarter. JPMorgan Chase & Co. now owns 59,269 shares of the company's stock worth $2,146,000 after purchasing an additional 28,026 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD bought a new stake in shares of Red Violet in the fourth quarter valued at about $1,002,000. 63.56% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Red Violet

In related news, insider Jeffrey Alan Dell sold 5,000 shares of the business's stock in a transaction on Friday, May 9th. The shares were sold at an average price of $46.20, for a total transaction of $231,000.00. Following the transaction, the insider now directly owns 172,968 shares in the company, valued at approximately $7,991,121.60. The trade was a 2.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Derek Dubner sold 10,000 shares of Red Violet stock in a transaction dated Friday, May 9th. The shares were sold at an average price of $46.21, for a total transaction of $462,100.00. Following the completion of the transaction, the chief executive officer now directly owns 580,379 shares of the company's stock, valued at approximately $26,819,313.59. This trade represents a 1.69% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 25,000 shares of company stock valued at $1,082,400. Corporate insiders own 8.90% of the company's stock.

Red Violet Stock Performance

Red Violet stock traded down $0.52 during midday trading on Thursday, reaching $46.82. The stock had a trading volume of 74,125 shares, compared to its average volume of 78,281. Red Violet, Inc. has a 1-year low of $20.89 and a 1-year high of $51.10. The firm's fifty day simple moving average is $42.95 and its 200-day simple moving average is $39.44. The stock has a market capitalization of $653.42 million, a P/E ratio of 130.06 and a beta of 1.78.

Red Violet Profile

Red Violet, Inc, a software and services company, specializes in proprietary technologies and applying analytical capabilities to deliver identity intelligence in the United States. It offers idiCORE, an investigative solution used to address various organizational challenges, which include due diligence, risk mitigation, identity authentication, fraud detection and prevention, customer acquisition, and regulatory compliance; and FOREWARN, an app-based solution that provides instant knowledge before face-to-face engagement with a consumer, as well as helps professionals to identify and mitigate risk.